Journal article
DMD pseudoexon mutations: Splicing efficiency, phenotype, and potential therapy
Annals of Neurology, Vol.63(1), pp.81-89
2008
Abstract
Objective
The degenerative muscle diseases Duchenne (DMD) and Becker muscular dystrophy result from mutations in the DMD gene, which encodes the dystrophin protein. Recent improvements in mutational analysis techniques have resulted in the increasing identification of deep intronic point mutations, which alter splicing such that intronic sequences are included in the messenger RNA as “pseudoexons.” We sought to test the hypothesis that the clinical phenotype correlates with splicing efficiency of these mutations, and to test the feasibility of antisense oligonucleotide (AON)–mediated pseudoexon skipping.
Methods
We identified three pseudoexon insertion mutations in dystrophinopathy patients, two of whom had tissue available for further analysis. For these two out-of-frame pseudoexon mutations (one associated with Becker muscular dystrophy and one with DMD), mutation-induced splicing was tested by quantitative reverse transcription polymerase chain reaction; pseudoexon skipping was tested using AONs composed of 2′-O-methyl–modified bases on a phosphorothioate backbone to treat cultured primary myoblasts.
Results
Variable amounts of pseudoexon inclusion correlates with the severity of the dystrophinopathy phenotype in these two patients. AON treatment directed at the pseudoexon results in the expression of full-length dystrophin in a DMD myoblast line.
Interpretation
Both DMD and Becker muscular dystrophy can result from out-of-frame pseudoexons, with the difference in phenotype being due to variable efficiency of the newly generated splicing signal. AON-mediated pseudoexon skipping therapy is a viable approach to these patients and would be predicted to result in increased expression of wild-type dystrophin protein.
Details
- Title
- DMD pseudoexon mutations: Splicing efficiency, phenotype, and potential therapy
- Authors/Creators
- O.L. Gurvich (Author/Creator) - University of UtahT.M. Tuohy (Author/Creator) - University of UtahM.T. Howard (Author/Creator) - University of UtahR.S. Finkel (Author/Creator) - Children's Hospital of PhiladelphiaL. Medne (Author/Creator) - Children's Hospital of PhiladelphiaC.B. Anderson (Author/Creator) - University of UtahR.B. Weiss (Author/Creator) - University of UtahS.D. Wilton (Author/Creator) - The University of Western AustraliaK.M. Flanigan (Author/Creator) - University of Utah
- Publication Details
- Annals of Neurology, Vol.63(1), pp.81-89
- Publisher
- Wiley
- Identifiers
- 991005541816207891
- Copyright
- © 2007 American Neurological Association
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
21 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.255 Musculoskeletal Disorders
- 1.255.628 Duchenne Muscular Dystrophy
- Web Of Science research areas
- Clinical Neurology
- Neurosciences
- ESI research areas
- Neuroscience & Behavior